Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study.
Hyo Sup KimBo Kyoung ParkSeong Koo KimSeung-Beom HanJae Wook LeeDong-Gun LeeNack-Gyun ChungBin ChoDae Chul JeongJin Han KangPublished in: BMC infectious diseases (2017)
Mortality due to P. aeruginosa bacteremia remained at 38.9% in this study, and more than one-third of the isolated strains were MDR. In this context, empirical antibiotic combination therapy to expand the antibiotic spectrum may be a strategy to reduce mortality due to P. aeruginosa bacteremia in febrile neutropenic patients.
Keyphrases
- combination therapy
- pseudomonas aeruginosa
- end stage renal disease
- cardiovascular events
- gram negative
- ejection fraction
- newly diagnosed
- chronic kidney disease
- escherichia coli
- urinary tract infection
- risk factors
- cystic fibrosis
- prognostic factors
- peritoneal dialysis
- metabolic syndrome
- cardiovascular disease
- staphylococcus aureus
- acinetobacter baumannii
- drug resistant
- chemotherapy induced